| |
Monday, December 5, 2022 | 11am ET / 8am PT The data behind the scenes must match and reflect the physical goods moving through the supply chain. In this webinar, we will discuss the four major components of compliance and how to get the data right to let the product flow. Register now.
|
|
|
Tuesday, November 29th, 2022 | 10am ET / 7am PT / 4pm CET Join our webinar to learn more on this fascinating topic where our experts will share their experiences and challenges in getting a repurposed drug to market successfully. The webinar will review case studies of successful drug repositioning to the nose to more intuitive and user friendly drug delivery. Register Now.
|
|
| By Nick Paul Taylor Jazz Pharmaceuticals has won FDA approval for a revised dosing schedule for its blood cancer therapy Rylaze, giving physicians the option to prescribe intramuscular doses of the drug on Monday, Wednesday and Friday. |
|
|
|
By Nick Paul Taylor The International Space Station National Laboratory is sponsoring another study of drug delivery in the thermosphere, partnering with Houston Methodist Research Institute and SpaceX to test a system in a model orbiting Earth. |
By Nick Paul Taylor Erytech is stepping up its focus on the drug delivery applications of its preclinical extracellular vesicles, pivoting toward the platform after halting development of its lead asset in the wake of a phase 3 flop. |
By Nick Paul Taylor ScPharmaceuticals has secured funding for commercialization of its recently approved on-body infusor, pricing a $50 million public offering ahead of the planned launch of the product early next year. |
|
Thursday, December 8th, 2022 | 11am ET / 8am PT Many manufacturers are looking to integrate hub enrollment into the EHR with the hope of connecting to provider workflows – but struggle to gain momentum. Learn about the future of patient enrollment into patient access and support services. Register now,
|
|
By Fraiser Kansteiner Arcutis' roflumilast cream 0.15%—a lower dose than the 0.3% formulation approved in late July as Zoryve—aced its primary endpoint and all secondary endpoints in a phase 3 study in patients 6 and older with mild to moderate atopic dermatitis. |
By Fraiser Kansteiner Kindeva will merge with ex-Pfizer subsidiary Meridian Medical Technologies to spawn a globetrotting drug-device contract development and manufacturing organization. Both companies have been in the drug delivery game for decades, but Meridian's reputation took a hit after multiple EpiPen entanglements. |
Fierce podcastsDon't miss an episode |
| This week on “The Top Line,” we share this week's headlines and discuss the 2022 honorees in our annual Fiercest Women in Life Sciences report. |
|
|---|
|
|
|
Thursday, December 8, 2022 | 2:00pm ET / 11:00am PT In this webinar, a group of experts will sit on this engaging panel discussion to examine the state of analytical characterization today, current regulatory guidance, best practices, and forward-looking considerations in early drug development that can lead to process improvement in the hopes of mitigating clinical holds. Register now!
|
|
| PodcastHow can Medical Affairs divisions bring greater value to their organizations and practitioners every day? Sponsored by: Medscape Medical Affairs |
| eBookSee how digital therapeutics (DTx) combined with patient engagement software offer a new opportunity for life science organizations (LSOs) to better serve and support patients. Download the guide from Health Catalyst to learn more. Sponsored by: Health Catalyst |
| WhitepaperAccelerating bioproduction towards high performance and scale Sponsored by: Capgemini Americas Inc. |
| WhitepaperElectronic health records (EHR) and patient registries are both important sources of real-world evidence – but which is right for your needs? Sponsored by: Veradigm Health |
| Whitepaper Learn the benefits of unlocking data insights across the healthcare and life sciences ecosystem. Sponsored by: NTT DATA |
| WhitepaperWhat is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
| ResearchLearn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
| WhitepaperHow can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
| Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
| Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
| Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
| Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
| |
|
